CClinicalTrials.gg
CompletedNCT00991666Updated Nov 14, 2014

Association Between Laser Interferometric Measurement of Fundus Pulsation and Pneumotonometric Measurement of Pulsatile Ocular Blood Flow in Patients With Age-related Macular Degeneration

An interventional study of blood flow measurement in Age-related Macular Degeneration, sponsored by Medical University of Vienna. Completed at 1 site in Austria. Open to participants aged 50 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-11-14.

Sponsored by Medical University of Vienna · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Non-randomized
Ages
50 Years to 90 Years
Sex
All
01

Study summary

Several methods have been proposed for the measurement of pulsatile ocular blood flow (POBF). The pneumatic tonometer, which is commercially available, assesses POBF by measurement of intraocular pressure (IOP) changes during the cardiac cycle. The investigators have recently developed a method for the measurement of ocular fundus pulsation, which is based on laser interferometry. In contrast to the Langham system the method is non-contractile and yields a high topographic resolution. Moreover, the pneumatic tonometer assesses the ocular pressure pulse, whereas ocular fundus pulsation is a point measure of the ocular volume pulse. These two parameters are related by the ocular rigidity, which refers to the mechanical properties of the eye coats.

Age-related macular degeneration (AMD) is the most common cause of blindness in the industrialized nations. The mechanisms behind this severe eye disease are, however, still obscure. It has been hypothesized that alterations in choroidal blood flow and ocular rigidity may contribute to the development and progression of AMD. However, there is currently little data to confirm this hypothesis. The present study is an attempt to investigate choroidal blood flow and ocular rigidity by employing laser interferometric measurement of fundus pulsation and pneumotonometric measurement of fundus pulsation.

02

Conditions studied

  • Age-related Macular Degeneration

Keywords

  • AMD
  • rigidity
  • pulsatile ocular blood flow
  • Physiology of the eye
03

In context

Macular Degeneration

1,474 studies on the registry are indexed under Macular Degeneration; 206 are open to participants now.

This study's enrollment of 100 is above the median of 51 across 985 interventional studies indexed under Macular Degeneration.

Browse Macular Degeneration studies →

Lead sponsor

Medical University of Vienna is the lead sponsor of 1,076 studies on the registry; 177 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients with AMD (defined as soft drusen > 63 µm, hyperpigmentation and/or hypopigmentation of the retinal pigment epithelium (RPE), RPE and associated neurosensory detachment, (peri)retinal hemorrhages, geographic atrophy of the RPE, or (peri)retinal fibrous scarring)
  • Age between 50 and 90 years

Exclusion criteria

Exclusion Criteria:

  • Evidence of any other retinal or choroidal vascular disease
  • Regular use of pentoxifylline in the last month before the trial period
  • Evidence of a choroidal neovascular membrane
  • Diabetes mellitus
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    1

    AMD Patients

    Procedure: blood flow measurement

  • Active comparator
    2

    healthy controls

    Procedure: blood flow measurement

Interventions

  • Procedureblood flow measurement

    Fundus pulsation amplitude measurement Pulsatile ocular blood flow measurement

06

What researchers measure

Primary outcomes

  1. Fundus pulsation amplitude

    Time frame: 10 minutes measurement of FPA

  2. Pulsatile ocular blood flow

    Time frame: 10 minutes measurement of pulsatile ocular blood flow

  3. Ocular rigidity

    Time frame: 10 minutes measurement of ocular rigidity

07

Study locations

1 site
  • Department of Clinical Pharmacology, Medical University of Vienna
    Vienna, Austria
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 14, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00991666
Lead sponsor
Medical University of Vienna
Responsible party
Gerhard Garhofer (Assoc. Prof. Priv. - Doz. Dr, Medical University of Vienna) — Principal investigator
First posted
Oct 8, 2009
Start date
Jul 2001
Primary completion
Feb 2011
Completion
Mar 2011
Last update
Nov 14, 2014

Study contacts

Leopold Schmetterer, Prof. Dr.
principal investigator · Department of Clinical Pharmacology, Medical University of Vienna

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion